Madeline Polak
Dana-Farber Cancer Institute
22 papers found
Refreshing results…
A phase II study of MK-2206, an AKT inhibitor, in uterine serous carcinoma
UploadA randomised trial of a web-based physical activity self-management intervention in COPD
Download from doi.orgMissing publications? Search for publications with a matching author name.